Viewing StudyNCT05856383



Ignite Creation Date: 2024-05-06 @ 6:58 PM
Last Modification Date: 2024-10-26 @ 2:58 PM
Study NCT ID: NCT05856383
Status: RECRUITING
Last Update Posted: 2023-05-12
First Post: 2023-04-02

Brief Title: Efficacy and Safety of Inetetamab Combined With Pyrotinib and Vinorelbine in ABC
Sponsor: Zhejiang Cancer Hospital
Organization: Zhejiang Cancer Hospital

Conditions & Keywords Data

Conditions:
Name
HER2-positive Advanced Breast Cancer
Keywords:
Name View
Advanced breast cancerHER2-positive View